Sign In
Buy KVUE
$17.32
-0.0300 (-0.173%)
At Close: Jun 02, 2026
J&J's consumer health spinoff Kenvue begins trading at $25.53 per share
02:05pm, Thursday, 04'th May 2023
J&J's consumer health IPO Kenvue opens to the NYSE.
Kenvue stock opens 16% above IPO, valuing the company at $47.7 billion
12:50pm, Thursday, 04'th May 2023
Kenvue Inc. shares KVUE, +16.16% were cheered in their Wall Street debut Thursday, as the Johnson & Johnson JNJ, -0.55% spinoff, with consumer brands including Tylenol, Band-Aid and Listerine, saw it'
J&J's consumer health spinoff Kenvue opens at $25.53, a 16% jump, in public market debut
12:49pm, Thursday, 04'th May 2023
Kenvue's debut is the biggest U.S. IPO since EV maker Rivian went public in 2021.
J&J spinoff Kenvue goes public
12:13pm, Thursday, 04'th May 2023
Kenvue CEO Thibaut Mongon joins 'Squawk on the Street' to discuss the company's IPO, which is the largest U.S. IPO since November 2021.
Johnson & Johnson spinoff Kenvue prices largest IPO since 2021
11:52am, Thursday, 04'th May 2023
Johnson & Johnson (NYSE:JNJ)'s consumer health unit Kenvue Inc just priced the biggest US IPO since 2021, in a spot of welcome news for capital markets. The spinoff is expected to achieve a valuatio
KVUE Stock Alert: 10 Things to Know as Kenvue Starts Trading
10:53am, Thursday, 04'th May 2023
Kenvue (NYSE: KVUE ) stock is set to start trading today as the company completes its spinoff from Johnson & Johnson (NYSE: JNJ ). Let's go over all of the details investors need to know about Kenvue
J&J Consumer-Health IPO Stock Kenvue to Raise $3.8 Billion
10:15am, Thursday, 04'th May 2023
Kenvue, which owns brands including Tylenol, Band-Aid, and Neutrogena, will begin trading Thursday. Shares were priced higher than an earlier range.
Johnson & Johnson's Kenvue IPO to command valuation of more than $40 billion in biggest public debut since 2021
07:38pm, Wednesday, 03'rd May 2023
A unit of Johnson & Johnson is headed for the biggest initial public offering in more than a year after its shares were priced near the top of the expected range Wednesday evening.
KVUE Stock: Should You Buy Into the Kenvue IPO?
11:00am, Wednesday, 03'rd May 2023
Johnson & Johnson (NYSE: JNJ ) will spin out its consumer health unit as Kenvue tomorrow, May 4. The stock will trade on the NYSE under the symbol KVUE.
J&J's Kenvue spinoff to hit IPO market this week in the biggest deal since late 2021
01:49pm, Monday, 01'st May 2023
Johnson & Johnson's consumer health company Kenvue is expected to hit the initial public offering market this week and mark the largest deal since late 2021.
KVUE Stock IPO: When Does Kenvue Go Public? What Is the Kenvue IPO Price Range?
01:32pm, Monday, 01'st May 2023
One of the season's most hotly anticipated initial public offerings (IPOs) is about to hit the market. Kenvue is a planned spinoff from Johnson & Johnson (NYSE: JNJ ), and the company is set to begin
US IPO Weekly Recap: J&J Spin-Off Kenvue Launches Billion-Dollar Deal In A 1 IPO Week
07:28am, Sunday, 30'th Apr 2023
The week's news was led by J&J's consumer health unit Kenvue, which set terms for its $3.3 billion listing on Monday. Six IPOs submitted initial filings this past week.
IPO Update: Kenvue Seeks $3.25 Billion IPO
01:53pm, Tuesday, 25'th Apr 2023
IPO Update: Kenvue Seeks $3.25 Billion IPO.
Does Johnson & Johnson's Kenvue IPO signal signs of life for US IPO market?
04:52am, Tuesday, 25'th Apr 2023
Are signs of life emerging from the moribund IPO market? If Johnson & Johnson (NYSE:JNJ)'s corporate advisors are correct, then, yes, possibly.
Johnson & Johnson spinoff Kenvue receives IPO value of $40 billion
05:59pm, Monday, 24'th Apr 2023
#Johnson&Johnson The Yahoo Finance Live team discusses the rise of Johnson & Johnson stock after a steady decline the past year, amid controversy regarding some products.
